Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

EPO

European, Industry news, News 01/07/2024

Claim interpretation using the description: Referral to the EPO Enlarged Board of Appeal

Euro 2024

European, Industry news, News 26/06/2024

The Role of Intellectual Property in UEFA Euro 2024

EU FLAG Canva

European, News, UPC 18/06/2024

Activity at the Unified Patent Court over the first 12 months of operation

Secerna Website Images 2023 (49)

European, Industry news 17/06/2024

Romania to Join the Unitary Patent System

Secerna Website Images 2023 (49) (1)

Events, News 12/06/2024

Secerna to attend Northern Powerhouse Investment Fund event in York

B012621

Events, News 11/06/2024

Secerna to attend BioFocus Conference 2024 in Newcastle

UK & USA

Industry news, News 10/06/2024

UK and US Intellectual Property Offices Join Forces on Standard Essential Patents

JP3 2544

Industry news, News, Team news 05/06/2024

Secerna Earns Fourth Consecutive IAM 1000 Recognition

EPO 2021

European, News, UPC 04/06/2024

Noteworthy Start for Europe's Unified Patent System One Year On

6 7 8 9 10 11 12 13 14 15 16